455 related articles for article (PubMed ID: 24571724)
21. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
22. Genomic and sequence variants of protein kinase A regulatory subunit type 1β (PRKAR1B) in patients with adrenocortical disease and Cushing syndrome.
Drougat L; Settas N; Ronchi CL; Bathon K; Calebiro D; Maria AG; Haydar S; Voutetakis A; London E; Faucz FR; Stratakis CA
Genet Med; 2021 Jan; 23(1):174-182. PubMed ID: 32895490
[TBL] [Abstract][Full Text] [Related]
23. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
24. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.
Bathon K; Weigand I; Vanselow JT; Ronchi CL; Sbiera S; Schlosser A; Fassnacht M; Calebiro D
Endocrinology; 2019 Feb; 160(2):447-459. PubMed ID: 30615103
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations.
Calebiro D; Bathon K; Weigand I
Horm Metab Res; 2017 Apr; 49(4):307-314. PubMed ID: 27813054
[TBL] [Abstract][Full Text] [Related]
26. Allelic Variants of
Mariani BMP; Nishi MY; Wanichi IQ; Brondani VB; Lacombe AMF; Charchar H; Pereira MAA; Srougi V; Tanno FY; Ceccato F; Regazzo D; Barbot M; Occhi G; Albiger NME; Vieira-Corrêa M; Kater CE; Scaroni C; Chambô JL; Zerbini MCN; Mendonca BB; Almeida MQ; Fragoso MCBV
Front Endocrinol (Lausanne); 2020; 11():36. PubMed ID: 32117062
[No Abstract] [Full Text] [Related]
27. A genetic and molecular update on adrenocortical causes of Cushing syndrome.
Lodish M; Stratakis CA
Nat Rev Endocrinol; 2016 May; 12(5):255-62. PubMed ID: 26965378
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological correlates of adrenal Cushing's syndrome.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
[TBL] [Abstract][Full Text] [Related]
29. Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome.
Di Dalmazi G; Timmers HJLM; Arnaldi G; Küsters B; Scarpelli M; Bathon K; Calebiro D; Beuschlein F; Hermus A; Reincke M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5651-5657. PubMed ID: 31276155
[TBL] [Abstract][Full Text] [Related]
30. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
[TBL] [Abstract][Full Text] [Related]
31. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
33. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
Nomura K; Saito H; Aiba M; Iihara M; Obara T; Takano K
Endocr J; 2003 Apr; 50(2):155-62. PubMed ID: 12803235
[TBL] [Abstract][Full Text] [Related]
34. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
[TBL] [Abstract][Full Text] [Related]
35. Clonal composition of human adrenocortical neoplasms.
Beuschlein F; Reincke M; Karl M; Travis WD; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
Cancer Res; 1994 Sep; 54(18):4927-32. PubMed ID: 7915195
[TBL] [Abstract][Full Text] [Related]
36. The genetics of adrenocortical tumors.
Espiard S; Bertherat J
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
[TBL] [Abstract][Full Text] [Related]
37. Cushing's syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity.
Walker C; Wang Y; Olivieri C; Karamafrooz A; Casby J; Bathon K; Calebiro D; Gao J; Bernlohr DA; Taylor SS; Veglia G
Sci Adv; 2019 Aug; 5(8):eaaw9298. PubMed ID: 31489371
[TBL] [Abstract][Full Text] [Related]
38. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.
Ronchi CL; Di Dalmazi G; Faillot S; Sbiera S; Assié G; Weigand I; Calebiro D; Schwarzmayr T; Appenzeller S; Rubin B; Waldmann J; Scaroni C; Bartsch DK; Mantero F; Mannelli M; Kastelan D; Chiodini I; Bertherat J; Reincke M; Strom TM; Fassnacht M; Beuschlein F;
J Clin Endocrinol Metab; 2016 Sep; 101(9):3526-38. PubMed ID: 27389594
[TBL] [Abstract][Full Text] [Related]
39. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
40. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
